These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Comparison of the impact of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management trial on prescribing patterns: a time-series analysis. Choudhry NK, Zagorski B, Avorn J, Levin R, Sykora K, Laupacis A, Mamdani M. Ann Pharmacother; 2008 Nov; 42(11):1563-72. PubMed ID: 18827174 [Abstract] [Full Text] [Related]
23. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. Pappone C, Augello G, Sala S, Gugliotta F, Vicedomini G, Gulletta S, Paglino G, Mazzone P, Sora N, Greiss I, Santagostino A, LiVolsi L, Pappone N, Radinovic A, Manguso F, Santinelli V. J Am Coll Cardiol; 2006 Dec 05; 48(11):2340-7. PubMed ID: 17161267 [Abstract] [Full Text] [Related]
24. Pharmacologic approaches to rhythm versus rate control in atrial fibrillation--where are we now? Wyse DG. Int J Cardiol; 2006 Jun 28; 110(3):301-12. PubMed ID: 16516313 [Abstract] [Full Text] [Related]
25. Risk of proarrhythmic events in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: a multivariate analysis. Kaufman ES, Zimmermann PA, Wang T, Dennish GW, Barrell PD, Chandler ML, Greene HL, Atrial Fibrillation Follow-up Investigation of Rhythm Management investigators. J Am Coll Cardiol; 2004 Sep 15; 44(6):1276-82. PubMed ID: 15364332 [Abstract] [Full Text] [Related]
26. Comparison of rate versus rhythm control in patients with atrial fibrillation and a pacemaker. Badheka AO, Marzouka GR, Rathod AD, Patel NJ, Myerburg RJ, Mitrani RD. Am J Cardiol; 2013 Jun 15; 111(12):1759-63. PubMed ID: 23540545 [Abstract] [Full Text] [Related]
27. Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies. Van Gelder IC, Wyse DG, Chandler ML, Cooper HA, Olshansky B, Hagens VE, Crijns HJ, RACE and AFFIRM Investigators. Europace; 2006 Nov 15; 8(11):935-42. PubMed ID: 16973686 [Abstract] [Full Text] [Related]
28. Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: clinical correlates and the effect of rhythm-control therapy. De Vos CB, Breithardt G, Camm AJ, Dorian P, Kowey PR, Le Heuzey JY, Naditch-Brûlé L, Prystowsky EN, Schwartz PJ, Torp-Pedersen C, Weintraub WS, Crijns HJ. Am Heart J; 2012 May 15; 163(5):887-93. PubMed ID: 22607868 [Abstract] [Full Text] [Related]
29. Rate-control vs. rhythm-control in patients with atrial fibrillation: a meta-analysis. Testa L, Biondi-Zoccai GG, Dello Russo A, Bellocci F, Andreotti F, Crea F. Eur Heart J; 2005 Oct 15; 26(19):2000-6. PubMed ID: 15872032 [Abstract] [Full Text] [Related]
30. Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion. Loricchio ML, Cianfrocca C, Pasceri V, Bianconi L, Auriti A, Calo L, Lamberti F, Castro A, Pandozi C, Palamara A, Santini M. Am J Cardiol; 2007 May 15; 99(10):1421-4. PubMed ID: 17493472 [Abstract] [Full Text] [Related]
31. Rate versus rhythm control in atrial fibrillation. Anthony KK, Mauro VF. Ann Pharmacother; 2004 May 15; 38(5):839-44. PubMed ID: 15039475 [Abstract] [Full Text] [Related]
34. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation. Saxon LA, Greenfield RA, Crandall BG, Nydegger CC, Orlov M, VAN Genderen R. J Cardiovasc Electrophysiol; 2006 May 15; 17(5):520-5. PubMed ID: 16684026 [Abstract] [Full Text] [Related]
35. Rate versus rhythm control in the management of patients with atrial fibrillation. Pelargonio G, Prystowsky EN. Nat Clin Pract Cardiovasc Med; 2005 Oct 15; 2(10):514-21. PubMed ID: 16186849 [Abstract] [Full Text] [Related]
36. Comparison of management patterns and clinical outcomes in patients with atrial fibrillation in Canada and the United States (from the analysis of the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] database). O'Hara GE, Charbonneau L, Chandler M, Vidaillet HJ, Philippon F, Sami M, Rocco TA, Padder FA, Champagne J, Pratt CM, Coutu B, Wyse DG, AFFIRM Investigators. Am J Cardiol; 2005 Sep 15; 96(6):815-21. PubMed ID: 16169368 [Abstract] [Full Text] [Related]